Home PageNews PageNxThera New Four-Year Data Demonstrate Rezūm™ Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms Boston Scientific Corporation (NYSE: BSX) today announced that data from a randomized clinical trial demonstrate…Arboretum_JDJanuary 29, 2019
News PageNxThera Boston Scientific Closes NxThera Acquisition Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The…Arboretum_JDApril 30, 2018
News PageNxThera Boston Scientific Announces Agreement To Acquire NxThera Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to…Arboretum_JDMarch 21, 2018
News PageNxThera NxThera Announces MTOPS Trial Data NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy…Arboretum_JDMarch 16, 2018
News PageNxThera NxThera Announces Rezūm® Center of Excellence Program Recognizing Top Urologists for Expertise in BPH Treatment NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy…Arboretum_JDFebruary 21, 2018
News PageNxThera Newly Published Economic Analysis Finds NxThera’s Minimally Invasive Rezūm® System Provides Cost-Effective Solution to Treat BPH NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy…Arboretum_JDJanuary 19, 2018
News PageNxThera NxThera Announces Three-Year Outcomes Data Demonstrating Durability of Its Minimally Invasive Rezūm® System for Enlarged Prostate Treatment NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy…Arboretum_JDJanuary 3, 2018